高级检索
当前位置: 首页 > 详情页

Effects of IFNG-AS1 and ANRIL on intestinal epithelial cells and their relationship with colitis

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Gastroenterology, The First Affiliated Hospital of Kunming Medical University, Yunnan Institute of Digestive Disease, Kunming, P.R. China [2]Department of Gastrointestinal and Hernia Surgery, The First Affiliated Hospital of Kunming Medical University, Yunnan Institute of Digestive, Kunming, P.R. China [3]Department of Gastroenterology, State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Gastroenterology, Guangdong Gastrointestinal Disease Research Center, Nanfang Hospital, Southern Medical University, Guangzhou, P.R. China
出处:
ISSN:

关键词: IFNG-AS1 ANRIL Colitis Intestinal epithelial cells Apoptosis

摘要:
OBJECTIVE: To explore the effects of IFNG-AS1 and ANRIL on intestinal epithelial cells and their relationship with colitis. PATIENTS AND METHODS: From May 2017 to May 2019, 118 colitis patients admitted to our hospital were selected as the research group (RG), and 124 healthy controls were selected as the control group (CG). In addition, the normal intestinal epithelial cells HIEC and HIEC-6 were purchased to detect the IFNG-AS1 and ANRIL in the peripheral blood of patients in the two groups, and the effects of IFNG-AS1 and ANRIL on the intestinal epithelial cells were analyzed. RESULTS: IFNG-AS1 and ANRIL were highly expressed in colitis (p< 0.050), and their combined detection had good diagnostic value for the occurrence of colitis and complications (p< 0.050). In intestinal epithelial cells transfected with IFNG-AS1 and ANRIL, it was found that inhibition of IFNG-AS1 and ANRIL remarkably increased the proliferation and decreased the apoptosis of intestinal epithelial cells (p< 0.050). CONCLUSIONS: IFNG-AS1 and ANRIL are highly expressed in colitis, and inhibiting their expression can promote the proliferation of intestinal epithelial cells and reduce apoptosis, which may be potential therapeutic targets for Crohn's colitis in the future.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 3 区 医学
小类 | 3 区 药学
最新[2025]版:
JCR分区:
出版当年[2019]版:
Q2 PHARMACOLOGY & PHARMACY
最新[2023]版:

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者机构: [1]Department of Gastroenterology, The First Affiliated Hospital of Kunming Medical University, Yunnan Institute of Digestive Disease, Kunming, P.R. China [3]Department of Gastroenterology, State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Gastroenterology, Guangdong Gastrointestinal Disease Research Center, Nanfang Hospital, Southern Medical University, Guangzhou, P.R. China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:87577 今日访问量:0 总访问量:721 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号